Otsuka Sues Apotex Again Over Generic Abilify

Law360, New York (October 23, 2008, 12:00 AM EDT) -- Japanese drugmaker Otsuka Pharmaceutical Co. Ltd. has slapped Apotex Inc. with a new lawsuit over Apotex's request to make yet another dosage of a generic version of Otsuka's schizophrenia drug Abilify, even as the companies spar over a key patent for the drug in a different action.

Otsuka filed an amended complaint against Apotex on Wednesday in the U.S. District Court for the District of New Jersey in response to the news that Apotex was seeking to expand its abbreviated new drug application for a generic...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.